Drug pipeline
Explore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Calcium/calmodulin-dependent protein kinase II (CaMKII) is a family of multifunctional serine/threonine-specific protein kinases that play a central role in calcium signaling pathways. CaMKII is widely expressed across many tissues and cell types, with particularly high abundance in the brain, heart, and skeletal muscle. It exists as a multimeric holoenzyme typically composed of 12 or 14 subunits. Activation occurs when intracellular calcium levels rise, leading to binding of calmodulin (CaM) to the regulatory domain and subsequent autophosphorylation. CaMKII regulates numerous cellular processes, including neuronal function, cardiac function, immune system function, and gene transcription. Dysregulation or aberrant activation has been linked to Alzheimer's disease, Angelman syndrome, and cardiac arrhythmias. Inhibition of CaMKII shows therapeutic potential for improving cardiac performance and reducing arrhythmic risk.
CaMKII inhibition
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Calcium/calmodulin-dependent protein kinase II (CaMKII).